Atlas Trials

Innate Pharma

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Innate Pharma

RecordFirmDate
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors (NCT06781983)Innate Pharma2025-01-24
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE) (NCT05742607)Innate Pharma2023-06-23
Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2 (NCT05321147)Innate Pharma2022-03-17
IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (NCT03902184)Innate Pharma2019-05-22
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors (NCT03665129)Innate Pharma2018-09-07

Track Innate Pharma automatically

Every clearance here is in the API, with alerts when new ones post.